Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations

Autor(es)

Franco, Luciana F. ^[1] ; Szarf, Gilberto ^[2] ; Dotto, Renata P. ^[1] ; Dib, Sergio A. ^[1] ; Moises, Regina S. ^[1] ; Giuffrida, Fernando M. A. ^{[3, 1]} ; Reis, Andre F. ^[1]

Afiliação do(s) autor(es)

^[1] Univ Fed Sao Paulo UNIFESP, Disciplina Endocrinol, Sao Paulo - Brazil

^[2] Univ Fed Sao Paulo UNIFESP, Dept Diagnost Imagem, Sao Paulo - Brazil

^[3] Univ Estado Bahia UNEB, Dept Ciencias Vida, Salvador, BA - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Diabetes Research and Clinical Practice; v. 176, JUN 2021.
• Citações Web of Science: 0

Resumo

Aims: Maturity- Onset Diabetes of the Young (MODY) caused by glucokinase (GCK) mutations is characterized by lifelong mild non-progressive hyperglycemia, with low frequency of coronary artery disease (CAD) compared to other types of diabetes. The aim of this study is to estimate cardiovascular risk by coronary artery calcification (CAC) score in this group. Materials and methods: Twenty-nine GCK-MODY cases, 26 normoglycemic controls (recruited among non-affected relatives/spouses of GCK mutation carriers), and 24 unrelated individuals with type 2 diabetes were studied. Patients underwent CAC score evaluation by computed tomography and were classified by Agatston score >= or < 10. Framingham Risk scores of CAD in 10 years were calculated. Results: Median {[}interquartile range] CAC score in GCK-MODY was 0 {[}0,0], similar to controls (0 {[}0,0], P = 0.49), but lower than type 2 diabetes (39 {[}0, 126], P = 2.6 x 10(-5)). A CAC score >= 10 was seen in 6.9% of the GCK group, 7.7% of Controls (P = 1.0), and 54.2% of individuals with type 2 diabetes (P = 0.0006). Median Framingham risk score was lower in GCK than type 2 diabetes (3% vs. 13%, P = 4 x 10(-6)), but similar to controls (3% vs. 4%, P = 0.66). Conclusions: CAC score in GCK-MODY is similar to control individuals from the same family and/or household and is significantly lower than type 2 diabetes. Besides demonstrating low risk of CAD in GCK-MODY, these findings may contribute to understanding the specific effect of hyperglycemia in CAD. (C) 2021 Elsevier B.V. All rights reserved. (AU)

• Processo FAPESP: 15/05123-9 - Estratificação de risco de doença cardiovascular em pacientes com Diabetes mellitus monogênico tipo MODY
• Beneficiário: André Fernandes Reis
• Modalidade de apoio: Auxílio à Pesquisa - Regular